35 related articles for article (PubMed ID: 35731616)
1. Inflammation after catheterisation mimicking tumour with squamous cell lung carcinoma in positron emission tomography.
Ono R; Iwahana T; Daimon M; Kato H; Aoki K; Abe K; Kobayashi Y
BMJ Case Rep; 2023 Feb; 16(2):. PubMed ID: 36731950
[No Abstract] [Full Text] [Related]
2. Computed DWI MRI Results in Superior Capability for N-Stage Assessment of Non-Small Cell Lung Cancer Than That of Actual DWI, STIR Imaging, and FDG-PET/CT.
Ohno Y; Yui M; Takenaka D; Yoshikawa T; Koyama H; Kassai Y; Yamamoto K; Oshima Y; Hamabuchi N; Hanamatsu S; Obama Y; Ueda T; Ikeda H; Hattori H; Murayama K; Toyama H
J Magn Reson Imaging; 2023 Jan; 57(1):259-272. PubMed ID: 35753082
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer patients.
Ohno Y; Koyama H; Yoshikawa T; Takenaka D; Kassai Y; Yui M; Matsumoto S; Sugimura K
Eur J Radiol; 2015 Nov; 84(11):2321-31. PubMed ID: 26231045
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
[TBL] [Abstract][Full Text] [Related]
5. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
Sommer G; Wiese M; Winter L; Lenz C; Klarhöfer M; Forrer F; Lardinois D; Bremerich J
Eur Radiol; 2012 Dec; 22(12):2859-67. PubMed ID: 22772365
[TBL] [Abstract][Full Text] [Related]
6. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT.
Ohno Y; Koyama H; Yoshikawa T; Nishio M; Aoyama N; Onishi Y; Takenaka D; Matsumoto S; Maniwa Y; Nishio W; Nishimura Y; Itoh T; Sugimura K
Radiology; 2011 Nov; 261(2):605-15. PubMed ID: 21926377
[TBL] [Abstract][Full Text] [Related]
7. Editorial for "Computed DWI Results in Superior Capability for N-Stage Assessment of Non-Small Cell Lung Cancer than that of Actual DWI, STIR Imaging and FDG-PET/CT".
Laue HOA; Persigehl T
J Magn Reson Imaging; 2023 Jan; 57(1):273-274. PubMed ID: 35731616
[No Abstract] [Full Text] [Related]
8. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.
Laking G; Price P
Thorax; 2001 Sep; 56 Suppl 2(Suppl 2):ii38-44. PubMed ID: 11514705
[No Abstract] [Full Text] [Related]
9. The role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review.
Joye I; Deroose CM; Vandecaveye V; Haustermans K
Radiother Oncol; 2014 Nov; 113(2):158-65. PubMed ID: 25483833
[TBL] [Abstract][Full Text] [Related]
10. The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review.
Mac Manus M; Hicks RJ
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1298-306. PubMed ID: 19028270
[No Abstract] [Full Text] [Related]
11. Non-Small-Cell Lung Cancer PET Imaging Beyond F18 Fluorodeoxyglucose.
Cheng G
PET Clin; 2018 Jan; 13(1):73-81. PubMed ID: 29157387
[TBL] [Abstract][Full Text] [Related]
12. State-of-the-Art FDG-PET imaging of lung cancer.
Gilman MD; Aquino SL
Semin Roentgenol; 2005 Apr; 40(2):143-53. PubMed ID: 15898411
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
